1Zucchelli P, Zuccala A. Can we accurately diagnose nephrosclersis?Nephrol Dial Transplant, 1995, 10(Suppl 6): 2.
2Brunner FP, Selwood NH. On behalf of the EDTA Registration Committee, Profile of patients on RRT in Europe and death rates due to major causes of death groups. Kidney lnt, 1992,42(Suppl 38): ,54.
3US Renal data system, in USRDS 1997 annual data report. The national institutes of Health, The National Institute of Diabetes and Digestive and :Kidney Diseases, Division of Kidney, Urologic, and Hematologic Disease.1997.
5Roaansky SJ, Hoover DR, King L, et al. The association of blood pressure levels and change in renal function in hypertensive and non-hypertensive subjects. Arch Intern Med, 1990, 150:2073.
6Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med, 1996, 334:13.
7Rostand SG, Brown G, Kirk KA, et al. Renal insufficiency in treated essential hypertension. N Engl J Med, 1989, 320:684.
8Walker WG, Neaton JD, Cutler JA, et al. Renal function change in hypertensive members of the multiple risk factor intervention trial. Racial and treatment effects. JAMA, 1992, 268:3085.
9Siewetrt-Delle A, Ljungman S, Andersson OK, et al.Does treated primary hypertensin lead to end-stage renal disease? A 20-year follow-up of the primary prevention study in Goteborg, Sweden. Nephrol Dial Transplant, 1998, 13:3084.
10Hsu CY. Dose treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomized, controlled trials. J Hum Hypertens, 2001, 15:99.
